Mechanistic Elucidation and Targeted Therapy of Organ Injury and Inflammation following Trauma

创伤后器官损伤和炎症的机制阐明和靶向治疗

基本信息

  • 批准号:
    10409732
  • 负责人:
  • 金额:
    $ 39.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Multiple organ dysfunction syndrome (MODS) is a leading cause of death after severe trauma, which is a leading cause of mortality worldwide. MODS is thought to be a consequence of a vicious cascade of excessive inflammation and coagulation abnormalities but remains incompletely understood. Recent advances in the resuscitation of trauma patients (such as whole blood transfusion and the use of tranexamic acid) have led to improved initial survival, yet these critically ill patients now stay alive to be at risk to develop MODS and other immune/inflammatory complications. This makes understanding how MODS occurs a critical and an immediate need in trauma. MODS is thought to arise in the setting of excessive innate immune activation and is associated with the late phase of trauma-induced coagulopathy (TIC). TIC is characterized by endothelial injury, excessive thrombosis manifesting as both severe small vessel thrombosis, which contributes to organ dysfunction, as well as deadly large vessel thromboembolic events. There is a critical need to identify a mechanistic link between the excessive inflammatory and innate immune responses and the defects in coagulation in order to understand MODS. The overarching goal of our research is to understand how trauma leads to organ injury through inflammation and clotting of blood vessels, or immunothrombosis. Our research focus is the central role of platelet function in driving immunothrombosis after trauma. Our preliminary data demonstrate that platelets are critical to the innate immune response after injury. Platelets are sentinel cells in immune function and serve a critical regulatory function by interacting with other inflammatory cells, and in this way are a major link between inflammation and thrombosis. Furthermore, trauma-induced `dysfunctional' platelets are key components to both drive TIC and to amplify inflammation and organ injury. Thus, we hypothesize that dysfunctional platelets and their interactions with other immune cells are critical regulators of MODS. There is an imminent need to develop research focusing on the prevention and management of organ injury and complications of inflammation/thrombosis, and this represents the key theme of the present proposal and research program. Furthermore, modern trauma resuscitation is rapidly changing to include new techniques which saves lives after injury. We must understand exactly how these interventions work to design the next great advance in resuscitation and also how they impact the risk of MODS. Essential to this is the need to develop targeted therapeutic strategies to treat the overwhelming morbidity after trauma. We propose to tackle the following key knowledge gaps in the field: 1) Understand the cellular mechanisms leading to micro-thrombotic organ injury in survivors after trauma 2) Unravel the immune and inflammatory consequences of modern trauma resuscitation 3) Design targeted interventions for post-traumatic organ injury and thrombosis
项目摘要/摘要:多器官功能障碍综合征(mods)是死亡的主要原因 严重的创伤,这是全球死亡率的主要原因。国防部被认为是 过度炎症和凝结异常的恶性级联 理解。创伤患者复苏的最新进展(例如全血输血和 使用曲霉素酸)导致最初的生存提高,但这些重症患者现在仍然活着 有发展MOD和其他免疫/炎症并发症的风险。这使得了解如何 国防部发生至关重要的创伤需求。人们认为在过度的情况下会出现mods 先天免疫激活,与创伤诱导的凝血病(TIC)的后期有关。 tic是 以内皮损伤为特征 这导致器官功能障碍以及致命的大型血管栓塞事件。有一个 确定过度炎症和先天免疫反应之间的机械联系的批判性需求 以及凝血中的缺陷以了解mod。 我们研究的总体目标是了解创伤如何通过 血管的炎症和凝结,或免疫骨骼病。我们的研究重点是核心角色 血小板功能在创伤后驱动免疫栓塞。我们的初步数据表明血小板是 受伤后对先天免疫反应至关重要。血小板是免疫功能的前哨细胞,并提供A 通过与其他炎症细胞相互作用,关键的调节功能,以这种方式是 炎症和血栓形成。此外,创伤引起的“功能失调”血小板是关键组成部分 驱动抽动和扩大炎症和器官损伤。因此,我们假设功能失调的血小板 它们与其他免疫细胞的相互作用是MOD的关键调节剂。迫在眉睫 开展研究重点是预防和管理器官损伤和并发症的研究 炎症/血栓形成,这代表了本提案和研究计划的关键主题。 此外,现代创伤复苏正在迅速改变,以包括挽救生命的新技术 受伤后。我们必须准确了解这些干预措施如何设计下一个巨大进步 复苏以及它们如何影响mod的风险。这是必不可少的 治疗创伤后压倒性发病率的治疗策略。 我们建议解决该领域的以下关键知识差距: 1)了解创伤后幸存者导致幸存者微栓性器官损伤的细胞机制 2)揭示现代创伤复苏的免疫和炎症后果 3)设计针对创伤后器官损伤和血栓形成的目标干预措施

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew D Neal其他文献

Precision in Transfusion Medicine.
输血医学的精确性。
  • DOI:
    10.1001/jama.2023.16134
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Matthew D Neal;Beverley J Hunt
  • 通讯作者:
    Beverley J Hunt
Time to First Whole Blood Associated With Survival-First (Whole) Blood?
首次全血的时间与生存优先(全)血相关?
  • DOI:
    10.1001/jamasurg.2023.7186
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    16.9
  • 作者:
    J. Sperry;Matthew D Neal
  • 通讯作者:
    Matthew D Neal
Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again?
氨甲环酸在创伤中的应用:受伤3小时后,何时再次使用安全有效?
  • DOI:
    10.1111/trf.17779
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Christopher D Barrett;Matthew D Neal;Jonathan G Schoenecker;Robert L. Medcalf;P. Myles
  • 通讯作者:
    P. Myles
Antithrombotic Testing Using Platelet Aggregometry Vs Small Volume Stenotic Microfluidic Device
  • DOI:
    10.1182/blood-2022-169344
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Lara Hoteit;Emily Mihalko;Katelin Rahn;Richard Steinman;Susan M. Shea;Matthew D Neal
  • 通讯作者:
    Matthew D Neal

Matthew D Neal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew D Neal', 18)}}的其他基金

Mechanisms of platelet exosome-mediated acute chest syndrome in sickle cell disease
血小板外泌体介导的镰状细胞病急性胸部综合征的机制
  • 批准号:
    10377458
  • 财政年份:
    2019
  • 资助金额:
    $ 39.7万
  • 项目类别:
Mechanisms of platelet exosome-mediated acute chest syndrome in sickle cell disease
血小板外泌体介导的镰状细胞病急性胸部综合征的机制
  • 批准号:
    9918971
  • 财政年份:
    2019
  • 资助金额:
    $ 39.7万
  • 项目类别:
Mechanistic Elucidation and Targeted Therapy of Platelet Dysfunction After Trauma
创伤后血小板功能障碍的机制阐明和靶向治疗
  • 批准号:
    9336940
  • 财政年份:
    2016
  • 资助金额:
    $ 39.7万
  • 项目类别:
Mechanistic Elucidation and Targeted Therapy of Platelet Dysfunction After Trauma
创伤后血小板功能障碍的机制阐明和靶向治疗
  • 批准号:
    9484277
  • 财政年份:
    2016
  • 资助金额:
    $ 39.7万
  • 项目类别:
Mechanistic Elucidation and Targeted Therapy of Organ Injury and Inflammation following Trauma
创伤后器官损伤和炎症的机制阐明和靶向治疗
  • 批准号:
    10649442
  • 财政年份:
    2016
  • 资助金额:
    $ 39.7万
  • 项目类别:
Diversity Supplement to R35 - Mechanistic Elucidation and Targeted Therapy of Organ Injury and Inflammation following Trauma
R35 的多样性补充 - 创伤后器官损伤和炎症的机制阐明和靶向治疗
  • 批准号:
    10627526
  • 财政年份:
    2016
  • 资助金额:
    $ 39.7万
  • 项目类别:

相似国自然基金

DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
  • 批准号:
    42207312
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
集成微流控芯片应用于高通量精准生物检体测定
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    60 万元
  • 项目类别:
    面上项目
硫酸盐还原菌生物膜活性的原位快速测定研究
  • 批准号:
    41876101
  • 批准年份:
    2018
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
冬虫夏草抗菌肽的序列测定及其生物学功能研究
  • 批准号:
    81803848
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Layilin as a modulator of platelet activation and thromboinflammation
Layilin 作为血小板活化和血栓炎症调节剂
  • 批准号:
    10607168
  • 财政年份:
    2023
  • 资助金额:
    $ 39.7万
  • 项目类别:
The TGF-Beta/MUC4 Signaling Axis in Circulating Tumor Cells of Metastatic Breast Cancer
转移性乳腺癌循环肿瘤细胞中的 TGF-β/MUC4 信号轴
  • 批准号:
    10751169
  • 财政年份:
    2023
  • 资助金额:
    $ 39.7万
  • 项目类别:
Regulation of Protein Kinase C Theta by Phosphorylation
通过磷酸化调节蛋白激酶 C Theta
  • 批准号:
    10679152
  • 财政年份:
    2023
  • 资助金额:
    $ 39.7万
  • 项目类别:
The Origin and Function of Lung Megakaryocytes
肺巨核细胞的起源和功能
  • 批准号:
    10677191
  • 财政年份:
    2023
  • 资助金额:
    $ 39.7万
  • 项目类别:
Impact of turbulence on blood in mechanical circulatory support
机械循环支持中湍流对血液的影响
  • 批准号:
    10634686
  • 财政年份:
    2022
  • 资助金额:
    $ 39.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了